Comparison of patients with IBD on treatment with Remicade and Inflectra
| Patients on treatment with Remicade (January to July 2015) | Patients on treatment with Inflectra (July to October 2015) | |
|---|---|---|
| Number of patients | 17 (CD 15, UC 2) | 24 (CD 18, UC 6) |
| Total number of infusions | 96 | 72 |
| Number of infusions per patient median (range) | 6 (2–8) | 3 (1–6) |
| Major infusion reaction | 1/17 (6%) | 1/24 (4%) |
| Patients with CD on Azathioprine | 12/15 (80%) | 15/18 (83%) |
| Patients with CD needing dose escalation | 3/15 (20%) | 5/18 (28%) |
| Patients with CD in remission at 3 months | 8/15 (53%) | 7/11 (64%) |
| Patients with UC in remission | 1/2 (50%) | 3/6 (50%) |
| Drug cost of 6 month’s treatment | £3500 | £2100 |